I don’t know about you but I am finding it a bit harder than usual to keep a “smile on the dial” – and I’m one of the lucky ...

Lupin Limited and Zydus Lifesciences Limited have received approval from the United States Food and Drug Administration ...

The field of partial reprogramming is transitioning from successful mouse studies to its first human clinical trials. At the heart of this experiment lies the discovery of Yamanaka ...

Scientists have identified a little-known receptor, GPR133, as a powerful regulator of bone strength. By activating it with a newly discovered compound called AP503, they were able to boost bone ...

The night after last year’s sports day, Enzo was admitted to the Women’s and Children’s Hospital with chest pains. After a ...

The Western Canadian premiere of Kimberly Akimbo brings veteran performers and new special effects to the Vancouver stage ...

Zydus Lifesciences Limited has received a tax demand order of Rs 14.20 million, including interest and penalty, for alleged ...

Shares of firms like Tata Motors, RVNL, RIL, Sun Pharma, RailTel, Zydus Lifesciences, and others will be in focus on ...

Sentynl will acquire full rights to the investigational drug candidate, Progerinin (SLC-D011), adding to its commercial portfolio of rare and ultra-rare disease products The agreement will allow ...

Sentynl will obtain full rights to Progerinin after specified milestones, while immediately collaborating with PRG S&T to accelerate clinical development for HGPS. Progerinin is designed to inhibit ...